Fund HoldingsCommodore Capital LP

Total Portfolio Value
$1.68B
Total Bought
$192.12M
Total Sold
$507.72M
Net Transaction
-$315.60M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
TANGO THERAPEUTICS INC(TNGX)02,250,000+2,250,000070,3354.19%+70,335
DEFINIUM THERAPEUTICS INC(DFTX)2,000,0002,000,000037,80094,0805.60%+56,280
RELAY THERAPEUTICS INC(RLAY)17,000,00012,000,000-5,000,000169,150224,52013.37%+55,370
ENLIVEN THERAPEUTICS INC3,275,0003,275,0000128,380166,2069.90%+37,826
EYEPOINT INC(EYPT)2,825,0004,600,000+1,775,00036,41465,7803.92%+29,366
EDITAS MEDICINE INC(EDIT)08,889,000+8,889,000028,8001.72%+28,800
AMYLYX PHARMACEUTICALS INC(AMLX)5,650,0005,650,000078,535101,4746.04%+22,939
INFLARX NV(IFRX)07,300,000+7,300,000016,3520.97%+16,352
LB PHARMACEUTICALS INC(LBRX)1,500,0001,500,000036,99048,6832.90%+11,693
AVALO THERAPEUTICS INC(AVTX)483,0001,018,319+535,3197,21118,8191.12%+11,607
ASSEMBLY BIOSCIENCES INC1,000,0001,415,000+415,00027,75038,8842.32%+11,134
ALTO NEUROSCIENCE INC(ANRO)2,723,1962,723,196061,21771,8654.28%+10,648
ALKERMES PLC(ALKS)4,200,0003,000,000-1,200,000148,512157,1859.36%+8,673
COGENT BIOSCIENCES INC(COGT)2,888,0073,050,000+161,993111,159118,0357.03%+6,876
AN2 THERAPEUTICS INC2,333,7132,933,680+599,9677,98114,1990.85%+6,218
RELMADA THERAPEUTICS INC(RLMD)633,9011,425,000+791,0994,4129,8610.59%+5,449
RESEARCH ALLIANCE CORP III0500,000+500,00005,3500.32%+5,350
INHIBIKASE THERAPEUTICS INC(IKT)5,397,4885,397,48809,06810,9570.65%+1,889
CENTURY THERAPEUTICS INC(IPSC)8,695,6528,695,652019,65221,3041.27%+1,652
VISTAGEN THERAPEUTICS INC(VTGN)02,788,620+2,788,62006300.04%+630
HELIX ACQUISITION CORP III(HLXC)500,000500,00005,0805,3200.32%+240
DAMORA THERAPEUTICS INC(DMRA)1,939,0001,939,000050,22050,4333.00%+213
PEPGEN INC(PEPG)4,475,0004,475,00007,9218,0550.48%+134
ZURA BIO LTD(ZURA)3,250,0003,250,000019,33819,1751.14%-162
LEONABIO INC(LONA)464,398464,39804,7744,2680.25%-506
PERSPECTIVE THERAPEUTICS INC(CATX)6,336,7826,336,782026,42421,6081.29%-4,816
PHARVARIS N V
COM
1,918,9701,425,000-493,97054,21149,2772.93%-4,934
SAB BIOTHERAPEUTICS INC(SABS)4,401,5002,870,000-1,531,50016,85811,1930.67%-5,665
KARYOPHARM THERAPEUTICS INC(KPTI)1,950,0000-1,950,00010,8620-10,861
PALISADE BIO INC(PALI)7,181,0620-7,181,06212,5670-12,567
SPYRE THERAPEUTICS INC(SYRE)1,912,380846,786-1,065,59496,46075,1784.48%-21,283
OCULAR THERAPEUTIX INC(OCUL)2,575,0000-2,575,00021,8100-21,810
SOLENO THERAPEUTICS INC652,4320-652,43221,8430-21,843
CORVUS PHARMACEUTICALS INC(CRVS)2,258,7350-2,258,73533,0450-33,045
KYMERA THERAPEUTICS INC(KYMR)750,000250,000-500,00062,46828,6681.71%-33,800
TYRA BIOSCIENCES INC(TYRA)2,475,0001,875,000-600,00094,79359,8883.57%-34,905
NURIX THERAPEUTICS INC(NRIX)2,275,0000-2,275,00035,2630-35,262
CELLDEX THERAPEUTICS INC NEW(CLDX)2,696,6161,350,000-1,346,61685,53750,2342.99%-35,303
XENON PHARMACEUTICALS INC(XENE)825,0000-825,00047,9740-47,974
ERASCA INC(ERAS)3,175,0000-3,175,00051,3720-51,371
NUVALENT INC833,600100,000-733,60085,40212,3500.74%-73,052
Page 1 of 1